CartaBio is a seed-stage biotech startup incubated through the Harvard Innovation Lab, headquartered in Boston, USA. The founding team consists of experienced industry experts at the intersection of AI and Bio (JnJ, Celgene, AZ, Pfizer, Moderna), as well as renowned professors from top universities (Harvard, MSU). Founded in 2023, the company has established collaborations with several multinational pharmaceutical companies (MNCs) and quickly achieved initial commercial validation in developing cell-centric translational biomarkers and drug programs. CartaBio is actively growing its revolutionary integrated AI-Lab-Data platform through collaborations with top research institutions, biobanks, and university labs around the world.
Company Details
- Employees
- 3
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://cartabio.ai
- Keywords
- Azome Therapeutics.
Cartabio Questions
Cartabio's website is https://cartabio.ai
Cartabio's LinkedIn profile is https://www.linkedin.com/company/cartabio
Cartabio has
3 employees.
View email and phone details for 3
employees at Cartabio.
Cartabio's industry is
Biotechnology Research
Cartabio's top competitors are
Regain Biomedicals,
Azome Therapeutics,
Amygo Solutions,
Ahersla Health, Inc.,
Isohelix,
Aridica,
Opticell Solutions Ab,
Tiferet Coaching,
深圳市人民医院,
Biolattice.
Cartabio's categories are Biotechnology Research
Cartabio's founding year is 2023
